Explore the Potential with AI-Driven Innovation
This extensive focused library is tailor-made using the latest virtual screening and parameter assessment technology, operated by the Receptor.AI drug discovery platform. This technique is more effective than traditional methods, offering compounds with improved activity, selectivity, and safety.
The compounds are cherry-picked from the vast virtual chemical space of over 60B molecules. The synthesis and delivery of compounds is facilitated by our partner Reaxense.
The library includes a list of the most promising modulators annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Also, each compound is presented with its optimal docking poses, affinity scores, and activity scores, providing a comprehensive overview.
We use our state-of-the-art dedicated workflow for designing focused libraries.
Fig. 1. The sreening workflow of Receptor.AI
Utilising molecular simulations, our approach thoroughly examines a wide array of proteins, tracking their conformational changes individually and within complexes. Ensemble virtual screening enables us to address conformational flexibility, revealing essential binding sites at functional regions and allosteric locations. Our rigorous analysis guarantees that no potential mechanism of action is overlooked, aiming to uncover new therapeutic targets and lead compounds across diverse biological functions.
Our library is unique due to several crucial aspects:
partner
Reaxense
upacc
O43196
UPID:
MSH5_HUMAN
Alternative names:
-
Alternative UPACC:
O43196; B0V033; B0V034; O60586; Q5BLU9; Q5SSR1; Q8IW44; Q9BQC7
Background:
MutS protein homolog 5 plays a pivotal role in DNA mismatch repair and meiotic recombination, ensuring genomic stability and proper segregation of chromosomes during meiosis. Its function facilitates crucial crossovers between homologs, underscoring its significance in genetic integrity.
Therapeutic significance:
MutS protein homolog 5 is linked to Premature ovarian failure 13 and Spermatogenic failure 74, conditions marked by early cessation of ovarian function and male infertility, respectively. Understanding the role of MutS protein homolog 5 could open doors to potential therapeutic strategies for these reproductive disorders.